Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Colgate-Palmolive
CL
$72.6B
| $108M | 0.07% |
1,434,805
-715,438
| -33% | -$56.8M |
|
277
FIVE9
FIVN
$2.45B
| $108M | 0.06% |
677,109
+329,780
| +95% | +$60.2M |
|
278
Fidelity National Financial
FNF
$12.7B
| $108M | 0.06% |
2,477,363
+493,515
| +25% | +$21.9M |
|
279
CALL
SPDR Gold Trust
GLD
$152B
| $108M | 0.06% |
656,600
+10,400
| +2% | +$1.74M |
|
280
CALL
Analog Devices
ADI
$182B
| $108M | 0.06% |
652,100
+619,600
| +1,906% | +$104M |
|
281
Kroger
KR
$35.5B
| $108M | 0.06% |
2,660,545
+2,301,415
| +641% | +$96.6M |
|
282
Honeywell
HON
$68.4B
| $107M | 0.06% |
536,250
-1,345,126
| -71% | -$287M |
|
283
PUT
Lam Research
LRCX
$393B
| $107M | 0.06% |
1,877,000
+730,000
| +64% | +$44.4M |
|
284
Intercontinental Exchange
ICE
$90.5B
| $106M | 0.06% |
924,691
+127,723
| +16% | +$15.2M |
|
285
PUT
iShares China Large-Cap ETF
FXI
$4.28B
| $106M | 0.06% |
2,720,100
+276,400
| +11% | +$11.4M |
|
286
CALL
Texas Instruments
TXN
$241B
| $106M | 0.06% |
549,400
+520,500
| +1,801% | +$99.2M |
|
287
PUT
Teladoc Health
TDOC
$1.16B
| $106M | 0.06% |
832,200
+145,000
| +21% | +$21.1M |
|
288
PUT
Automatic Data Processing
ADP
$112B
| $105M | 0.06% |
527,400
+407,100
| +338% | +$83.9M |
|
289
CALL
Charter Communications
CHTR
$17.9B
| $105M | 0.06% |
144,900
+8,200
| +6% | +$6.22M |
|
290
CALL
Snap
SNAP
$8.86B
| $105M | 0.06% |
1,419,800
+145,700
| +11% | +$10.5M |
|
291
Cigna
CI
$73.3B
| $105M | 0.06% |
523,728
-379,070
| -42% | -$82.4M |
|
292
Huntington Bancshares
HBAN
$34.4B
| $105M | 0.06% |
6,766,055
+2,805,490
| +71% | +$41.3M |
|
|
JOBS
293
DELISTED
51job Inc
JOBS
| $104M | 0.06% |
1,499,962
+45,960
| +3% | +$3.38M |
|
|
BBL
294
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
| $104M | 0.06% |
2,050,636
+154,723
| +8% | +$9.3M |
|
295
Bank of America
BAC
$431B
| $104M | 0.06% |
2,446,799
-466,197
| -16% | -$18.8M |
|
296
PUT
iShares Biotechnology ETF
IBB
$10.7B
| $104M | 0.06% |
641,100
+115,900
| +22% | +$19.5M |
|
|
CMA
297
DELISTED
Comerica
CMA
| $103M | 0.06% |
1,275,790
+390,421
| +44% | +$28.1M |
|
298
State Street
STT
$51.4B
| $102M | 0.06% |
1,198,443
+372,787
| +45% | +$32.4M |
|
|
CXP
299
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $101M | 0.06% |
5,299,981
+4,840,366
| +1,053% | +$84.3M |
|
|
SPLK
300
PUT
DELISTED
Splunk Inc
SPLK
| $101M | 0.06% |
694,500
+45,700
| +7% | +$6.65M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.